Skip to content

Ropivacaine After Sternotomy

Ropivacaine Infusion to Alleviate Postoperative Pain After Cardiac Surgery

Status
Completed
Phases
Phase 4
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT02449486
Acronym
NAROSYD
Enrollment
90
Registered
2015-05-20
Start date
2014-01-31
Completion date
2017-12-31
Last updated
2018-04-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Postoperative Pain

Keywords

Requirement of postoperative pain medication

Brief summary

Continuous ropivacaine infusion to sternotomy wound after coronary artery bypass grafting (CABG) or heart valve surgery to diminish postoperative pain.

Detailed description

A multiporous catheter will be introduced into sternotomy wound to CABG or heart valve surgery patients and continuous ropivacaine infusion 4 ml/h will be started immediately after surgery. Ropivacaine infusion will be administered during 48 postoperative hours. All patients receive patient controlled analgesia (PCA) oxycodone after extubation in the PACU. All patients receive a standardized anesthesia during surgery.

Interventions

DRUGRopivacaine

Sponsors

Kuopio University Hospital
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
TRIPLE (Subject, Caregiver, Investigator)

Eligibility

Sex/Gender
ALL
Age
18 Years to 80 Years
Healthy volunteers
No

Inclusion criteria

* Elective CABG or heart valve surgery patients

Exclusion criteria

* Psychic disorders * Sleep apnea syndrome * Diabetes mellitus (insulin dependent) * Obesity, body mass index (BMI) ≥ 35 * Cardiac insufficiency, ejection fraction (EF) ≤ 30

Design outcomes

Primary

MeasureTime frameDescription
Postoperative oxycodone consumption48 postoperative hourspostoperative PCA administered oxycodone

Secondary

MeasureTime frameDescription
Pain measured with Visual Analog Scale48 postoperative hourspain measured with VAS at rest and on movement

Countries

Finland

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026